Search
Menu
Meadowlark Optics - SEE WHAT

Thermo Fisher Scientific Inc.

Facebook X LinkedIn Email
Thermo Fisher Scientific Inc. of Waltham, Mass., has acquired Intrinsic Bioprobes Inc. of Tempe, Ariz., to enhance its work flow for biomarker research and diagnostics. Intrinsic Bioprobes’ portfolio, including its mass spectrometric immunoassay, will enable Thermo Fisher to offer its life sciences research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection. Intrinsic Bioprobes manufactures immuno-enrichment sample-preparation tools used in quantitative mass spectrometry.

Thermo Fisher also has completed the acquisition of Phadia of Uppsala, Sweden, a provider of blood tests for clinical diagnosis and monitoring of allergies and autoimmune diseases, adding it to its Specialty Diagnostics business.
Gentec Electro-Optics Inc   - Measure Your Laser MR

Published: October 2011
Glossary
mass spectrometry
An instrumental technique that utilizes the mass-to-charge ratio of charged particles as recorded from a mass spectrometer in order to determine the mass of a particle as well as the chemical makeup, or elemental ionic composition of a given sample or molecule.
AmericasArizonabiomarker researchBiophotonicsblood test monitoringblood tests for clinical diagnosisBusinessclinical diagnosticsdiagnosticsearnings per shareEPSEuropeIntrinsic Bioprobes Inc.life sciences researchmass spectrometric immunoassaymass spectrometryMassachusettsMSIANew YorkPhadiaprotein biomarker detectionRapidScanspectroscopySwedenTest & Measurementtesting for allergies and autoimmune diseasesThermo FisherThermo Fisher Scientific Inc.Thermo Fisher Specialty Diagnostics

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.